{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T06:40:53Z","timestamp":1785652853277,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01867-z","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:02:22Z","timestamp":1727946142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS\/FTD"],"prefix":"10.1186","volume":"12","author":[{"given":"Elodie","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Piorkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kosco-Vilbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-2706","authenticated-orcid":false,"given":"Tamara","family":"Seredenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Afroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"1867_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106050","volume":"179","author":"T Afroz","year":"2023","unstructured":"Afroz T, Chevalier E, Audrain M, Dumayne C, Ziehm T, Moser R et al (2023) Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS\/FTD. Neurobiol Dis 179:106050. https:\/\/doi.org\/10.1016\/j.nbd.2023.106050","journal-title":"Neurobiol Dis"},{"key":"1867_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2533\/chimia.2019.380","volume":"73","author":"T Afroz","year":"2019","unstructured":"Afroz T, Perez-Berlanga M, Polymenidou M (2019) Structural transition, function and dysfunction of TDP-43 in neurodegenerative diseases. Chimia (Aarau) 73:380\u2013390. https:\/\/doi.org\/10.2533\/chimia.2019.380","journal-title":"Chimia (Aarau)"},{"key":"1867_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602\u2013611. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093","journal-title":"Biochem Biophys Res Commun"},{"key":"1867_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41586-023-06405-w","volume":"620","author":"D Arseni","year":"2023","unstructured":"Arseni D, Chen R, Murzin AG, Peak-Chew SY, Garringer HJ, Newell KL et al (2023) TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620:898\u2013903. https:\/\/doi.org\/10.1038\/s41586-023-06405-w","journal-title":"Nature"},{"key":"1867_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04199-3","author":"D Arseni","year":"2021","unstructured":"Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M et al (2021) Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04199-3","journal-title":"Nature"},{"key":"1867_CR6","doi-asserted-by":"publisher","first-page":"fcad306","DOI":"10.1093\/braincomms\/fcad306","volume":"5","author":"M Audrain","year":"2023","unstructured":"Audrain M, Egesipe AL, Tentillier N, Font L, Ratnam M, Mottier L et al (2023) Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF. Brain Commun 5:fcad306. https:\/\/doi.org\/10.1093\/braincomms\/fcad306","journal-title":"Brain Commun"},{"key":"1867_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20\u201338. https:\/\/doi.org\/10.1002\/ana.23937","journal-title":"Ann Neurol"},{"key":"1867_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","volume":"22","author":"E Buratti","year":"2018","unstructured":"Buratti E (2018) TDP-43 post-translational modifications in health and disease. Expert Opin Ther Targets 22:279\u2013293. https:\/\/doi.org\/10.1080\/14728222.2018.1439923","journal-title":"Expert Opin Ther Targets"},{"key":"1867_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","volume":"99","author":"Y Chornenkyy","year":"2019","unstructured":"Chornenkyy Y, Fardo DW, Nelson PT (2019) Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy. Lab Invest 99:993\u20131007. https:\/\/doi.org\/10.1038\/s41374-019-0196-y","journal-title":"Lab Invest"},{"key":"1867_CR10","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 6:5845. https:\/\/doi.org\/10.1038\/ncomms6845","journal-title":"Nat Commun"},{"key":"1867_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","volume":"24","author":"AE Conicella","year":"2016","unstructured":"Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24:1537\u20131549. https:\/\/doi.org\/10.1016\/j.str.2016.07.007","journal-title":"Structure"},{"key":"1867_CR12","doi-asserted-by":"publisher","first-page":"24178","DOI":"10.18632\/oncotarget.4680","volume":"6","author":"X Ding","year":"2015","unstructured":"Ding X, Ma M, Teng J, Teng RK, Zhou S, Yin J et al (2015) Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget 6:24178\u201324191. https:\/\/doi.org\/10.18632\/oncotarget.4680","journal-title":"Oncotarget"},{"issue":"339\u2013357","key":"1867_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.02.038","volume":"102","author":"F Gasset-Rosa","year":"2019","unstructured":"Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L et al (2019) Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102(339\u2013357):e337. https:\/\/doi.org\/10.1016\/j.neuron.2019.02.038","journal-title":"Neuron"},{"key":"1867_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1172\/JCI44867","volume":"121","author":"LM Igaz","year":"2011","unstructured":"Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T et al (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 121:726\u2013738. https:\/\/doi.org\/10.1172\/JCI44867","journal-title":"J Clin Invest"},{"key":"1867_CR15","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139:3187\u20133201. https:\/\/doi.org\/10.1093\/brain\/aww237","journal-title":"Brain"},{"key":"1867_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1741","author":"S Karanth","year":"2020","unstructured":"Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW et al (2020) Prevalence and clinical phenotype of quadruple misfolded proteins in older adults. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1741","journal-title":"JAMA Neurol"},{"key":"1867_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","volume":"138","author":"I Kawakami","year":"2019","unstructured":"Kawakami I, Arai T, Hasegawa M (2019) The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol 138:751\u2013770. https:\/\/doi.org\/10.1007\/s00401-019-02077-x","journal-title":"Acta Neuropathol"},{"key":"1867_CR18","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.3390\/ijms22126442","volume":"22","author":"A Kouhi","year":"2021","unstructured":"Kouhi A, Pachipulusu V, Kapenstein T, Hu P, Epstein AL, Khawli LA (2021) Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives. Int J Mol Sci 22:6442. https:\/\/doi.org\/10.3390\/ijms22126442","journal-title":"Int J Mol Sci"},{"key":"1867_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41593-023-01341-4","volume":"26","author":"ST Kumar","year":"2023","unstructured":"Kumar ST, Nazarov S, Porta S, Maharjan N, Cendrowska U, Kabani M et al (2023) Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat Neurosci 26:983\u2013996. https:\/\/doi.org\/10.1038\/s41593-023-01341-4","journal-title":"Nat Neurosci"},{"key":"1867_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2051-5960-2-33","volume":"2","author":"LK Kwong","year":"2014","unstructured":"Kwong LK, Irwin DJ, Walker AK, Xu Y, Riddle DM, Trojanowski JQ et al (2014) Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins. Acta Neuropathol Commun 2:33. https:\/\/doi.org\/10.1186\/2051-5960-2-33","journal-title":"Acta Neuropathol Commun"},{"key":"1867_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","volume":"22","author":"F Laferriere","year":"2019","unstructured":"Laferriere F, Maniecka Z, Perez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock EM et al (2019) TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci 22:65\u201377. https:\/\/doi.org\/10.1038\/s41593-018-0294-y","journal-title":"Nat Neurosci"},{"key":"1867_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65\u201378. https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"1867_CR23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s12035-019-01810-7","volume":"57","author":"C Maurel","year":"2020","unstructured":"Maurel C, Chami AA, Thepault RA, Marouillat S, Blasco H, Corcia P et al (2020) A role for SUMOylation in the formation and cellular localization of TDP-43 aggregates in amyotrophic lateral sclerosis. Mol Neurobiol 57:1361\u20131373. https:\/\/doi.org\/10.1007\/s12035-019-01810-7","journal-title":"Mol Neurobiol"},{"key":"1867_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/NEN.0b013e3181ee7d85","volume":"69","author":"AC McKee","year":"2010","unstructured":"McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW et al (2010) TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69:918\u2013929. https:\/\/doi.org\/10.1097\/NEN.0b013e3181ee7d85","journal-title":"J Neuropathol Exp Neurol"},{"key":"1867_CR25","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527. https:\/\/doi.org\/10.1093\/brain\/awz099","journal-title":"Brain"},{"key":"1867_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms10010232","volume":"10","author":"M Neumann","year":"2009","unstructured":"Neumann M (2009) Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 10:232\u2013246. https:\/\/doi.org\/10.3390\/ijms10010232","journal-title":"Int J Mol Sci"},{"key":"1867_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137\u2013149. https:\/\/doi.org\/10.1007\/s00401-008-0477-9","journal-title":"Acta Neuropathol"},{"key":"1867_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"1867_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4:124\u2013134. https:\/\/doi.org\/10.1016\/j.celrep.2013.06.007","journal-title":"Cell Rep"},{"key":"1867_CR30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/nan.12732","volume":"47","author":"S Porta","year":"2021","unstructured":"Porta S, Xu Y, Lehr T, Zhang B, Meymand E, Olufemi M et al (2021) Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol Appl Neurobiol 47:1033\u20131049. https:\/\/doi.org\/10.1111\/nan.12732","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1867_CR31","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ et al (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9:4220. https:\/\/doi.org\/10.1038\/s41467-018-06548-9","journal-title":"Nat Commun"},{"key":"1867_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-023-01592-z","volume":"11","author":"H Riemenschneider","year":"2023","unstructured":"Riemenschneider H, Simonetti F, Sheth U, Katona E, Roth S, Hutten S et al (2023) Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo. Acta Neuropathol Commun 11:112. https:\/\/doi.org\/10.1186\/s40478-023-01592-z","journal-title":"Acta Neuropathol Commun"},{"key":"1867_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mus.21386","volume":"40","author":"M Salajegheh","year":"2009","unstructured":"Salajegheh M, Pinkus JL, Taylor JP, Amato AA, Nazareno R, Baloh RH et al (2009) Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40:19\u201331. https:\/\/doi.org\/10.1002\/mus.21386","journal-title":"Muscle Nerve"},{"key":"1867_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/mcp.M800390-MCP200","volume":"9","author":"NT Seyfried","year":"2010","unstructured":"Seyfried NT, Gozal YM, Dammer EB, Xia Q, Duong DM, Cheng D et al (2010) Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics 9:705\u2013718. https:\/\/doi.org\/10.1074\/mcp.M800390-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"1867_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010606","volume":"19","author":"Y Tamaki","year":"2023","unstructured":"Tamaki Y, Ross JP, Alipour P, Castonguay CE, Li B, Catoire H et al (2023) Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids. PLoS Genet 19:e1010606. https:\/\/doi.org\/10.1371\/journal.pgen.1010606","journal-title":"PLoS Genet"},{"key":"1867_CR36","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380\u20133391. https:\/\/doi.org\/10.1093\/brain\/aws230","journal-title":"Brain"},{"key":"1867_CR37","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1093\/brain\/awad145","volume":"146","author":"AL Young","year":"2023","unstructured":"Young AL, Vogel JW, Robinson JL, McMillan CT, Ossenkoppele R, Wolk DA et al (2023) Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. Brain 146:2975\u20132988. https:\/\/doi.org\/10.1093\/brain\/awad145","journal-title":"Brain"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01867-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01867-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01867-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:02:44Z","timestamp":1727946164000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01867-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1867"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01867-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for autopsy and usage of tissue for research purposes had been obtained from probands or their legal representative in accordance with local institutional review boards. All animal procedures were performed according to institutional guidelines approved by respective country\u2019s governmental ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.A. and T.S. are coinventors on a patent application, publication number WO2020\/234473. R.O., T.A. and T.S. are coinventors on a patent application, publication number WO2022\/034228. E.C., M.R., R.O., A.F., K.P., A.P., M.V., T.S. are employees of AC Immune and entitled to options and\/or shares. M.A. and T.A. were employee of AC Immune at the time of this study. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}